Shi-Wen X - Search Results

1

Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Chen Y, Shi-Wen X, van Beek J, Kennedy L, McLeod M, Renzoni EA, Bou-Gharios G, Wilcox-Adelman S, Goetinck PF, Eastwood M, Black CM, Abraham DJ, Leask A. Chen Y, et al. Am J Pathol. 2005 Dec;167(6):1699-711. doi: 10.1016/s0002-9440(10)61252-7. Am J Pathol. 2005. PMID: 16314481 Free PMC article.

2

Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen.

Shi-Wen X, Panesar M, Vancheeswaran R, Mason J, Haskard D, Black C, Olsen I, Abraham D. Shi-Wen X, et al. Arthritis Rheum. 1994 Nov;37(11):1689-97. doi: 10.1002/art.1780371119. Arthritis Rheum. 1994. PMID: 7526872

3

Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.

Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO, Dubois RM, Black CM. Denton CP, et al. Br J Rheumatol. 1995 Nov;34(11):1048-54. doi: 10.1093/rheumatology/34.11.1048. Br J Rheumatol. 1995. PMID: 8542206

4

Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis.

Shi-Wen X, Denton CP, McWhirter A, Bou-Gharios G, Abraham DJ, du Bois RM, Black CM. Shi-Wen X, et al. Arthritis Rheum. 1997 Jul;40(7):1237-44. doi: 10.1002/1529-0131(199707)40:7<1237::AID-ART7>3.0.CO;2-Y. Arthritis Rheum. 1997. PMID: 9214423

5

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.

Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Bunn CC, et al. Br J Rheumatol. 1998 Jan;37(1):15-20. doi: 10.1093/rheumatology/37.1.15. Br J Rheumatol. 1998. PMID: 9487245

6

Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers.

Denton CP, Shi-Wen X, Sutton A, Abraham DJ, Black CM, Pearson JD. Denton CP, et al. Clin Exp Immunol. 1998 Nov;114(2):293-300. doi: 10.1046/j.1365-2249.1998.00721.x. Clin Exp Immunol. 1998. PMID: 9822290 Free PMC article.

7

Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial.

Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X. Black CM, et al. Arthritis Rheum. 1999 Feb;42(2):299-305. doi: 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R. Arthritis Rheum. 1999. PMID: 10025924 Free article. Clinical Trial.

8

Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts.

Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Abraham DJ, et al. J Biol Chem. 2000 May 19;275(20):15220-5. doi: 10.1074/jbc.275.20.15220. J Biol Chem. 2000. PMID: 10809757 Free article.

9

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, Fonseca C, du Bois RM, Martin GR, Black CM, Abraham DJ. Shi-wen X, et al. Exp Cell Res. 2000 Aug 25;259(1):213-24. doi: 10.1006/excr.2000.4972. Exp Cell Res. 2000. PMID: 10942593

10

CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.

Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. Holmes A, et al. J Biol Chem. 2001 Apr 6;276(14):10594-601. doi: 10.1074/jbc.M010149200. Epub 2001 Jan 4. J Biol Chem. 2001. PMID: 11152469 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters